Literature DB >> 19589716

Clinical changes of cervical dystonia pattern in long-term botulinum toxin treated patients.

Fernanda Martins Maia1, Aline Kozoroski Kanashiro, Hsin Fen Chien, Lílian Regina Gonçalves, Egberto Reis Barbosa.   

Abstract

Cervical dystonia (CD) is a complex disorder but the response to long-term botulinum toxin (BTX) therapy is satisfactory in most cases. Bad results are attributed by some authors to changes in muscle activation. Our purpose is to verify if the change in head deviation affects negatively the response to BTX therapy in a long-term follow-up, and if there are any differences in clinical parameters of these patients in comparison to those with stable pattern. From a total of 88 patients evaluated at the Movement Disorders Clinics of Hospital das Clinicas - University of São Paulo School of Medicine between January 1993 and December 2005, 67 were included. In 24 (35.8%) change in pattern of CD was observed, in a medium follow-up period of 80 months. The time between onset of dystonia and the diagnosis of pattern change was 9.7 years. Comparing with patients with no changes in CD pattern, there were no significant statistical differences. Improvement of symptoms around 60% was reported in both groups. In conclusion, the change in head deviation observed in CD was not responsible for bad response to therapy with BTX and there were no significant differences between both groups.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19589716     DOI: 10.1016/j.parkreldis.2009.06.004

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  7 in total

1.  Long-Term Abobotulinumtoxin A Treatment of Cervical Dystonia.

Authors:  A R Bentivoglio; E Di Stasio; D Mulas; M L Cerbarano; T Ialongo; A Laurienzo; Martina Petracca
Journal:  Neurotox Res       Date:  2017-05-06       Impact factor: 3.911

2.  Physical therapy program for cervical dystonia: a study of 20 cases.

Authors:  Mariana Araujo Ribeiro Queiroz; Hsin Fen Chien; Flávio Augusto Sekeff-Sallem; Egberto Reis Barbosa
Journal:  Funct Neurol       Date:  2012 Jul-Sep

Review 3.  Efficacy and safety of long-term botulinum toxin treatment in craniocervical dystonia: a systematic review.

Authors:  Carlo Colosimo; Dorina Tiple; Alfredo Berardelli
Journal:  Neurotox Res       Date:  2012-02-23       Impact factor: 3.911

Review 4.  Systematic review and meta-analysis of the duration of clinical effect of onabotulinumtoxinA in cervical dystonia.

Authors:  Wallace A Marsh; Deirdre M Monroe; Mitchell F Brin; Conor J Gallagher
Journal:  BMC Neurol       Date:  2014-04-27       Impact factor: 2.474

5.  Selective peripheral denervation for cervical dystonia: long-term follow-up.

Authors:  A Tommy Bergenheim; Erik Nordh; Eva Larsson; Marwan I Hariz
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-10-31       Impact factor: 10.154

6.  Brief considerations on the dispensation profile of the botulinum toxin type A by the Brazilian Unified Health System for treatment of dystonias: Datasus data.

Authors:  Hsin Fen Chien; Ana Lucia Zuma de Rosso; André Sobierajski Dos Santos; Carlos Roberto de Mello Rieder; Debora Palma Maia; Delson José da Silva; Marcio da Cunha Andrade; Marcus Vinicius Della Coletta; Maria do Desterro Leiros da Costa; Nasser Allam; Roberto César Pereira do Prado; Vanderci Borges; Vitor Tumas; Wagner de Goes Horta
Journal:  eNeurologicalSci       Date:  2016-07-19

7.  The Impact of the Course of Disease before Botulinum Toxin Therapy on the Course of Treatment and Long-Term Outcome in Cervical Dystonia.

Authors:  Harald Hefter; Isabelle Schomaecker; Max Schomaecker; Dietmar Rosenthal; Sara Samadzadeh
Journal:  Toxins (Basel)       Date:  2021-07-16       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.